Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study

Abstract Objectives To investigate the safety and effectiveness of mepolizumab (MPZ), an anti-interleukin-5 antibody, as remission induction therapy for severe eosinophilic granulomatosis with polyangiitis (EGPA). Methods The clinical courses of patients with severe EGPA over 6 months were retrospec...

Full description

Bibliographic Details
Main Authors:	Masanobu Ueno, Ippei Miyagawa, Takafumi Aritomi, Koichi Kimura, Shigeru Iwata, Kentaro Hanami, Syunsuke Fukuyo, Satoshi Kubo, Yusuke Miyazaki, Shingo Nakayamada, Yoshiya Tanaka
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Series:	Arthritis Research & Therapy
Subjects:	Eosinophilic granulomatosis with polyangiitis Corticosteroid Mepolizumab Induction therapy
Online Access:	https://doi.org/10.1186/s13075-022-02845-3

Similar Items

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
by: Masanobu Ueno, et al.
Published: (2021-03-01)

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
by: Giuseppe A. Ramirez, et al.
Published: (2022-12-01)

Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan
by: Takashi Yamane, et al.
Published: (2023-06-01)

Switching from omalizumab to mepolizumab therapy improved extra‐pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis
by: Yu‐Hsuan Chen, et al.
Published: (2022-01-01)

Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab
by: Yoshiro Kai, et al.
Published: (2022-02-01)

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
by: Nami Masumoto, et al.
Published: (2023-05-01)

Granulomatosis with polyangiitis
by: Zubayer Ahmad, et al.
Published: (2016-12-01)

INTERLEUKIN-5 IS A NEW TARGET IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
by: T. V. Beketova, et al.
Published: (2020-06-01)

Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis
by: Martina Uzzo, et al.
Published: (2021-11-01)

Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations
by: Ryu Watanabe, et al.
Published: (2023-09-01)

A case of refractory peripheral neuropathy associated with eosinophilic granulomatosis with polyangiitis with successful tapering of systemic corticosteroid and reduced dosing frequency of high-dose intravenous immunoglobulin after combined use of mepolizumab
by: Kentaro Kawate, et al.
Published: (2024-04-01)

Recurrent atelectasis and brain infarction in a patient with anti-neutrophil antibody negative eosinophilic granulomatosis with polyangiitis: a case report
by: Ken-ei Sada, et al.
Published: (2021-09-01)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
by: Michele V. Quan, et al.
Published: (2018-11-01)

Limited granulomatosis with polyangiitis presenting as an isolated lung lesion
by: Shameera Begum, et al.
Published: (2020-01-01)

Management of Severe Asthma in Eosinophilic Granulomatosis with Polyangiitis with Interleukin-5-Targeted Therapies: Current Status and Report of Two Cases
by: Ciro Romano, et al.
Published: (2022-11-01)

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis
by: Michele Iudici, et al.
Published: (2016-10-01)

Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis
by: Osamu Matsuno, et al.
Published: (2022-01-01)

Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis
by: Ji Eun Lee, et al.
Published: (2024-04-01)

Granulomatosis with polyangiitis: A case report and brief review of literature
by: Dhairya A Lakhani, MD, et al.
Published: (2021-11-01)

Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge
by: Joanna Wojciechowska, et al.
Published: (2016-03-01)

Granulomatosis with polyangiitis: An atypical initial presentation
by: Catarina Vilaça Pereira, et al.
Published: (2022-01-01)

Granulomatosis with polyangiitis in Poland – epidemiological study
by: Krzysztof Kanecki, et al.
Published: (2014-06-01)

Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
by: M. Benucci, et al.
Published: (2013-05-01)

Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
by: Santi Nolasco, et al.
Published: (2023-06-01)

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
by: Masayoshi Harigai, et al.
Published: (2019-05-01)

Granulomatosis with Polyangiitis with Ocular Manifestations
by: Lukpan Orazbekov, et al.
Published: (2021-04-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response
by: Mark Lai, et al.
Published: (2023-03-01)

Meningeal involvement in granulomatosis with polyangiitis
by: Andreia Brito, et al.
Published: (2023-04-01)

Granulomatosis with polyangiitis – diagnostic difficulties?
by: Marta Madej, et al.
Published: (2014-11-01)

Granulomatosis with polyangiitis patient with retinitis as an initial manifestation
by: Valdez Melo Dos Anjos Filho, et al.
Published: (2022-01-01)

Submandibular salivary gland involvement in granulomatosis with polyangiitis
by: Mohamed F. Abdelghany, et al.
Published: (2020-01-01)

Lung involvement in childhood onset granulomatosis with polyangiitis
by: Giovanni Filocamo, et al.
Published: (2017-04-01)

An unusual case of granulomatosis with polyangiitis with unilateral parotid gland enlargement
by: Toktam Safari Giv, et al.
Published: (2023-11-01)

A case of granulomatosis with polyangiitis mimicking lung malignancy
by: Michael Han, et al.
Published: (2021-09-01)

Endobronchial Lesion in Eosinophilic Granulomatosis with Polyangiitis
by: Guan-Liang Chen, et al.
Published: (2017-12-01)

Hepatic Artery Aneurysm in Granulomatosis with Polyangiitis
by: Sora S. Boustany, et al.
Published: (2021-11-01)

Risk factors and treatment of pneumothorax secondary to granulomatosis with polyangiitis: a clinical analysis of 25 cases
by: Xuhua Shi, et al.
Published: (2018-01-01)

Acute motor axonal neuropathy in a case of granulomatosis with polyangiitis
by: Ioan-Cristian Lupescu, et al.
Published: (2020-12-01)

Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis
by: Jang Woo Ha, et al.
Published: (2023-12-01)